TYK2 Inhibitors and compositions and methods thereof.
OA22320AActive Publication Date: 2026-09-30LYNK PHARMACEUTICALS CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- OA1202500402
- Authority / Receiving Office
- OA · OA
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2024-06-14
- Publication Date
- 2026-09-30
- Estimated Expiration
- 2044-06-14
Abstract
The invention provides a novel class of therapeutic agents that are safe and effective TYK2 inhibitors and pharmaceutical compositions of these compounds and methods of preparation and use thereof against various TYK2-mediated diseases and disorders.
Need to check novelty before this filing date? Find Prior Art